Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
---|---|---|---|---|---|---|---|---|
CancerPDF_ID3409 | VLNLGPITR | Uromodulin | Urine | NA | CE-MS-TOF | Bladder cancer | Downregulated in cancer vs normal | 21591268 |
CancerPDF_ID4103 | ADEIIIRDLNIKI | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID4263 | ALNIRVGGTGMFTV | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID4272 | ALQPMVSALNIRVGGTGMFTV | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID4673 | DQSRVLNLGPI | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID4984 | FMYLSDSRCSGF | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID5300 | GSVIDQSRVLNLGP | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID5520 | IRVGGTGMF | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID5521 | IRVGGTGMFT | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID5805 | LFQTPSYTQPYQGSSV | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6269 | NFACSYPLDMKV | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6290 | NIRVGGTGMFTV | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6558 | QMFRFAGNYDLV | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6710 | RMALFQTPSYTQPYQGSSV | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6980 | SLKTALQPMVSALNI | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6981 | SLKTALQPMVSALNIRV | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID6982 | SLLEHRLECGANDMKV | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID8391 | YTQPYQGSSVTLSTE | Isoform 1 of Uromodulin | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
CancerPDF_ID9964 | SGSVIDQSRV | Uromodulin | Urine | 1047.5336 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10031 | SRVLNLGPITR | Uromodulin | Urine | 1225.7265 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10069 | VVENGESSQGRF | Uromodulin | Urine | 1308.6102 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10115 | VIDQSRVLNLGPI | Uromodulin | Urine | 1423.811 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10146 | DQSRVLNLGPITR | Uromodulin | Urine | 1468.7924 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10169 | SVIDQSRVLNLGPI | Uromodulin | Urine | 1510.8126 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10178 | VIDQSRVLNLGPIT | Uromodulin | Urine | 1524.8219 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10203 | GSVIDQSRVLNLGPI | Uromodulin | Urine | 1567.8415 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10213 | IDQSRVLNLGPITR | Uromodulin | Urine | 1581.8746 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10225 | SVIDQSRVLNLGPIT | Uromodulin | Urine | 1611.8874 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10249 | SGSVIDQSRVLNLGPI | Uromodulin | Urine | 1654.9003 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10256 | GSVIDQSRVLNLGPIT | Uromodulin | Urine | 1668.9135 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10262 | VIDQSRVLNLGPITR | Uromodulin | Urine | 1680.9787 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10298 | SGSVIDQSRVLNLGPIT | Uromodulin | Urine | 1755.975 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10305 | SVIDQSRVLNLGPITR | Uromodulin | Urine | 1767.9996 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10327 | VIDQSRVLNLGPITRK | Uromodulin | Urine | 1809.1074 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10334 | GSVIDQSRVLNLGPITR | Uromodulin | Urine | 1825.0741 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10378 | SGSVIDQSRVLNLGPITR | Uromodulin | Urine | 1912.0595 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10436 | SGSVIDQSRVLNLGPITRK | Uromodulin | Urine | 2040.2504 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10748 | LNLGPITR | Uromodulin | Urine | 883.5165 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10763 | VLNLGPITR | Uromodulin | Urine | 982.6002 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID11080 | NA | UROM_HUMAN | Urine | 1912.106 | MALDI-TOF | Clear cell renal carcinoma | Downregulated with increse in tumor mass | 26482227 |